Cardiovascular Outcomes with Sotagliflozin
N Engl J Med
.
2021 Apr 15;384(15):1470-1471.
doi: 10.1056/NEJMc2102961.
Author
Piero Baglioni
1
Affiliation
1
Prince Charles Hospital, Merthyr Tydfil, United Kingdom Piero.Baglioni@wales.nhs.uk.
PMID:
33852786
DOI:
10.1056/NEJMc2102961
No abstract available
Publication types
Letter
Comment
MeSH terms
Diabetic Ketoacidosis*
Glycosides
Humans
Renal Insufficiency, Chronic*
Substances
Glycosides
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol